Activity

Filter

Cancel
Date Panel Item Activity
14 actions
Cerebral Palsy v2.0 TCF4 Gene migrated from ENSG00000196628 to ENSG00000196628 (gene set migration)
Cerebral Palsy v1.194 TCF4 Clare van Eyk reviewed gene: TCF4: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 38693247; Phenotypes: Pitt-Hopkins syndrome, MIM# 610954; Mode of inheritance: None
Cerebral Palsy v1.2 TCF4 Chirag Patel Classified gene: TCF4 as Green List (high evidence)
Cerebral Palsy v1.2 TCF4 Chirag Patel Gene: tcf4 has been classified as Green List (High Evidence).
Cerebral Palsy v1.1 TCF4 Chirag Patel Classified gene: TCF4 as Green List (high evidence)
Cerebral Palsy v1.1 TCF4 Chirag Patel Gene: tcf4 has been classified as Green List (High Evidence).
Cerebral Palsy v1.1 TCF4 Chirag Patel Classified gene: TCF4 as Green List (high evidence)
Cerebral Palsy v1.1 TCF4 Chirag Patel Gene: tcf4 has been classified as Green List (High Evidence).
Cerebral Palsy v1.0 TCF4 Chirag Patel reviewed gene: TCF4: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 33528536; Phenotypes: Pitt-Hopkins syndrome, MIM# 610954; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Cerebral Palsy v0.190 TCF4 Zornitza Stark Marked gene: TCF4 as ready
Cerebral Palsy v0.190 TCF4 Zornitza Stark Gene: tcf4 has been classified as Amber List (Moderate Evidence).
Cerebral Palsy v0.190 TCF4 Zornitza Stark Classified gene: TCF4 as Amber List (moderate evidence)
Cerebral Palsy v0.190 TCF4 Zornitza Stark Gene: tcf4 has been classified as Amber List (Moderate Evidence).
Cerebral Palsy v0.189 TCF4 Zornitza Stark gene: TCF4 was added
gene: TCF4 was added to Cerebral Palsy. Sources: Expert Review
Mode of inheritance for gene: TCF4 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes for gene: TCF4 were set to Pitt-Hopkins syndrome, MIM# 610954
Review for gene: TCF4 was set to AMBER
Added comment: Well established gene-disease association. Severe ID, seizures, dysmorphic features, but can be ataxic. Not specifically identified in CP cohorts.
Sources: Expert Review